A systematic review of the economic value proposition for commercially available nonsurgical weight‐loss interventions
Authors' conclusion
Evidence of cost-effectiveness for commercially available, evidence-based, nonsurgical weight-loss interventions is mixed. There is no evidence for cost-saving weight-loss medications and only weak evidence for behavioral and weight-loss interventions. Results provide a call to action to generate more robust evidence of the economic value proposition for these interventions.
Study context
- Population
- Economic evaluations of commercially available weight-loss products and services shown to result in clinically significant weight loss20 studies · 32 comparisons
- Comparison
- Commercially available nonsurgical weight-loss interventions
- Outcome
- Evidence of cost-effectiveness or cost savings
Pooled result
As reported in the abstract
Comparisons showing evidence of cost-effectiveness
Pharmaceutical
10 of 20 comparisons
10 events
Nonpharmaceutical
4 of 12 comparisons
4 events
- Nonpharmaceutical comparisons claiming cost savings
- 5
Original publication
A systematic review of the economic value proposition for commercially available nonsurgical weight‐loss interventions. Obesity (Silver Spring). Published 25 May 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →